NG
TMO icon

Novem Group’s Thermo Fisher Scientific TMO Stock Holding History

Novem Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Buy
+413
New +$198K 0.02% 425
2025
Q3 		– Sell
-495
Closed -$201K – 447
2025
Q2 		$201K Sell
495
-152
-23% -$63.6K 0.03% 382
2025
Q1 		$322K Buy
647
+78
+14% +$42.2K 0.05% 277
2024
Q4 		$296K Buy
+569
New +$313K 0.04% 288

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Novem Group's TMO Position: Q2 2026 in Review

Novem Group opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 413 shares worth $207K. The stake represents 0.02% of the portfolio and ranks #425 among its holdings. This is a return to the name: Novem Group previously reported a position in TMO as recently as Q2 2025.

Novem Group first reported a position in TMO in Q4 2024 and has held it in 4 quarters since. The position peaked at $322K in Q1 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Novem Group held 413 shares of Thermo Fisher Scientific worth $207K as of Q2 2026.
  • Thermo Fisher Scientific was a new Novem Group position in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Novem Group's portfolio in Q2 2026, its #425 holding.
  • Novem Group first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 4 quarters since.
  • Novem Group's Thermo Fisher Scientific position peaked at $322K in Q1 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.